245 related articles for article (PubMed ID: 8672735)
1. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension.
Pilette C; Moreau R; Sogni P; Kirstetter P; Cailmail S; Pussard E; Lebrec D
Eur J Pharmacol; 1996 Sep; 312(1):63-8. PubMed ID: 8891579
[TBL] [Abstract][Full Text] [Related]
3. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
[TBL] [Abstract][Full Text] [Related]
4. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis.
Braillon A; Cailmail S; Gaudin C; Lebrec D
J Hepatol; 1993 Jan; 17(1):86-90. PubMed ID: 8445224
[TBL] [Abstract][Full Text] [Related]
5. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension].
Albornoz L; Bandi JC; Sánchez S; Spinedi E; Canteros G; De Paula JA; Galdame O; Mastai R
Medicina (B Aires); 1994; 54(1):17-24. PubMed ID: 7990681
[TBL] [Abstract][Full Text] [Related]
6. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
Wu Y; Burns RC; Sitzmann JV
Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic haemodynamic effects of naftazone in portal hypertensive rats.
Sogni P; Yang S; Pilette C; Moreau R; Gadano A; Avenard G; Bloy C; Lebrec D
Eur J Pharmacol; 1998 Feb; 344(1):37-43. PubMed ID: 9570445
[TBL] [Abstract][Full Text] [Related]
8. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat.
García-Pagán JC; Fernández M; Bernadich C; Pizcueta P; Piqué JM; Bosch J; Rodés J
Am J Physiol; 1994 Dec; 267(6 Pt 1):G984-90. PubMed ID: 7810666
[TBL] [Abstract][Full Text] [Related]
9. Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats.
Lee FY; Colombato LA; Albillos A; Groszmann RJ
Gastroenterology; 1993 Nov; 105(5):1464-70. PubMed ID: 8224649
[TBL] [Abstract][Full Text] [Related]
10. Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats.
Wu ZY; Chen XS; Qiu JF; Cao H
World J Gastroenterol; 2005 Feb; 11(5):752-5. PubMed ID: 15655838
[TBL] [Abstract][Full Text] [Related]
11. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension.
Pizcueta MP; Piqué JM; Bosch J; Whittle BJ; Moncada S
Br J Pharmacol; 1992 Jan; 105(1):184-90. PubMed ID: 1596680
[TBL] [Abstract][Full Text] [Related]
12. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
[TBL] [Abstract][Full Text] [Related]
13. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
[TBL] [Abstract][Full Text] [Related]
14. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.
Fernández M; García-Pagán JC; Casadevall M; Bernadich C; Piera C; Whittle BJ; Piqué JM; Bosch J; Rodés J
Gastroenterology; 1995 May; 108(5):1487-95. PubMed ID: 7537235
[TBL] [Abstract][Full Text] [Related]
15. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
J Hepatol; 1995 Sep; 23(3):341-7. PubMed ID: 8550999
[TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide and endothelin-1 in a portal hypertensive rat model.
Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Tanoue K; Sugimachi K
Scand J Gastroenterol; 2000 Oct; 35(10):1097-105. PubMed ID: 11099065
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and pancreatic islet blood flow after induced portal hypertension in rats.
Jansson L; Andersson A
Pancreas; 1997 Apr; 14(3):280-4. PubMed ID: 9094159
[TBL] [Abstract][Full Text] [Related]
18. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
20. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.
Lee FY; Wang SS; Tsai YT; Lin HJ; Lin HC; Chu CJ; Wu SL; Tai CC; Lee SD
J Hepatol; 1997 Mar; 26(3):687-93. PubMed ID: 9075678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
